Vimarsana
Biggest News Aggregation in the World

Bruce Cree News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bruce Cree. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bruce Cree Today - Breaking & Trending Today

A Biological Framework for Multiple Sclerosis - Vimarsana News

A Biological Framework for Multiple Sclerosis

MS can be considered a spectrum, researchers proposed

Bristol Myers Squibb Announces New Data from the Long-Term DAYBREAK Study Reinforcing Efficacy and Safety of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Sclerosis - Vimarsana News

Bristol Myers Squibb Announces New Data from the Long-Term DAYBREAK Study Reinforcing Efficacy and Safety of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Sclerosis

Sustained efficacy was confirmed with an annualized relapse rate of 0.098 and 67% of patients were relapse-free at six years Safety was consistent with prior findings and the established safety...

Bristol Myers: positive results in multiple sclerosis -February 29, 2024 at 08:08 am EST - Vimarsana News

Bristol Myers: positive results in multiple sclerosis -February 29, 2024 at 08:08 am EST

Bristol Myers Squibb today announced new results from a Phase 3 trial, demonstrating the long-term efficacy and safety profile of Zeposia in patients with relapsing forms of multiple sclerosis . In...

KYV-101 Multiple Sclerosis Treatment Gets FDA Clearance - Physical Therapy Products - Vimarsana News

KYV-101 Multiple Sclerosis Treatment Gets FDA Clearance - Physical Therapy Products

A study will seek to answer whether CAR T-cell therapy using KYV-101 offers a new treatment option for patients living with MS.

Ozanimod for Relapsing MS Shows Long-Term Safety, Efficacy - Vimarsana News

Ozanimod for Relapsing MS Shows Long-Term Safety, Efficacy

"Serious infections did not vary by age, and there were too few serious events to identify any age-related trends by specific TEAE," the authors reported.